

MJR was supported by the Veterans Affairs National Quality Scholars Program with use of facilities at Veterans Health Administration Tennessee Valley Healthcare System and in part by a grant from the Urology Care Foundation Research Scholars Program and the American Urological Association Southeastern Section Research Scholar Fund. Exceptions may be made for uncertain or equivocal. Data were requested from the Research Derivative, and data management was facilitated by the use of Vanderbilt University's Research Electronic Data Capture (REDCap) system, which are both supported by the Vanderbilt Institute for Clinical and Translational Research grant ( UL1TR000445 from the National Center for Advancing Translational Sciences/National Institutes of Health). microhematuria and will not be reimbursed when billed with an ICD10 code in the R31 Hematuria range. microhematuria due to sickle cell disease, priapism due to sickle cell disease. Access to this feature is available in the following products: Find-A-Code Essentials. Subscribe to Codify by AAPC and get the code details in a flash. This code description may also have Includes, Excludes, Notes, Guidelines, Examples and other information. Funding: This study was funded by a grant from the National Cancer Institute to study variation in evaluation for hematuria ( 1R03CA173807-01 Principal Investigator, DAB) and a Vanderbilt Institute for Clinical and Translational Research grant (VR4961). Code will be replaced by October 2015 and relabeled as ICD-10-CM 282.60. ICD-10 code R31 for Hematuria is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified.
